The U.S. Food and Drug Administration (FDA) said pharmaceutical companies have recalled more than 500,000 bottles of the blood pressure medication Prazosin hydrochloride over concerns that they may contain chemicals that cause cancer.
Nationally voluntarily issued by New Jersey-based Teva Pharmaceuticals USA and drug distributor Amerisource Health Services. reminisce More than 580,000 bottles of Prazosin capsules in various strengths were sold earlier this month, according to the FDA.
Doctors prescribe prazosin, which relaxes blood vessels to help lower blood pressure. It is also prescribed for nightmares and other sleep disorders caused by post-traumatic stress disorder.
The FDA said: executive order Many of the recalled drugs may contain nitrosamine impurities, which are considered potentially carcinogenic, giving many of them a Class II hazard classification, according to a posting online.
According to the FDA: N-nitrosamine impurities A class of potentially carcinogenic chemicals that can form during the manufacture or storage of drugs.
